Cargando…
Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy Biomarker
SIMPLE SUMMARY: Data show that the global cancer burden continues to grow. It is estimated that there were 19.3 million new cancer cases and nearly 10 million cancer deaths worldwide in 2020. Therefore, a comprehensive analysis is of great significance for the accurate diagnosis and effective treatm...
Autores principales: | Deng, Xinna, Wang, Yashu, Guo, Hao, Wang, Qian, Rao, Shuting, Wu, Haijiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649301/ https://www.ncbi.nlm.nih.gov/pubmed/37958409 http://dx.doi.org/10.3390/cancers15215235 |
Ejemplares similares
-
Pan-cancer analysis and experimental validation of DTL as a potential diagnosis, prognosis and immunotherapy biomarker
por: Tang, Yumei, et al.
Publicado: (2023) -
Global research trends in unilateral ureteral obstruction-induced renal fibrosis: A bibliometric and visualized study
por: Wang, Yashu, et al.
Publicado: (2023) -
Pan-cancer analysis and experimental validation revealed the m6A methyltransferase KIAA1429 as a potential biomarker for diagnosis, prognosis, and immunotherapy
por: Ma, Chao, et al.
Publicado: (2023) -
YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy
por: Hu, Jian, et al.
Publicado: (2021) -
Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy
por: Cui, Zhiwei, et al.
Publicado: (2023)